The complaint, spearheaded by the law firm Robbins LLP, centers on the claim that Good Foods failed to disclose critical operational failures following the June 2024 acquisition. While management repeatedly signaled that the integration was progressing as planned, plaintiffs contend the company lost key personnel, suffered from bloated administrative costs, and struggled with significant product quality issues linked to a new pea protein supplier. These internal challenges allegedly eroded margins and led to a reliance on unsustainable promotional discounting.
The consequences of these issues became public on April 9, 2026, when the company reported that OWYN quarterly sales had contracted by nearly 17%. The disclosure of a $187 million impairment charge and a slashed sales outlook triggered a sharp market reaction, with shares falling from $14.41 to $10.44 over two trading days. By July 2026, cumulative impairments reached $200 million, representing 70% of the original purchase price.

Comments (0)
No comments yet. Be the first!